Suppr超能文献

增强型snoMEN载体有助于建立GFP-HIF-1α蛋白替代人类细胞系。

Enhanced snoMEN Vectors Facilitate Establishment of GFP-HIF-1α Protein Replacement Human Cell Lines.

作者信息

Ono Motoharu, Yamada Kayo, Bensaddek Dalila, Afzal Vackar, Biddlestone John, Ortmann Brian, Mudie Sharon, Boivin Vincent, Scott Michelle S, Rocha Sonia, Lamond Angus I

机构信息

Centre for Gene Regulation and Expression, School of Life Sciences, University of Dundee, Dundee, United Kingdom.

Department of Biochemistry and RNA Group, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Canada.

出版信息

PLoS One. 2016 Apr 29;11(4):e0154759. doi: 10.1371/journal.pone.0154759. eCollection 2016.

Abstract

The snoMEN (snoRNA Modulator of gene ExpressioN) vector technology was developed from a human box C/D snoRNA, HBII-180C, which contains an internal sequence that can be manipulated to make it complementary to RNA targets, allowing knock-down of targeted genes. Here we have screened additional human nucleolar snoRNAs and assessed their application for gene specific knock-downs to improve the efficiency of snoMEN vectors. We identify and characterise a new snoMEN vector, termed 47snoMEN, that is derived from box C/D snoRNA U47, demonstrating its use for knock-down of both endogenous cellular proteins and G/YFP-fusion proteins. Using multiplex 47snoMEM vectors that co-express multiple 47snoMEN in a single transcript, each of which can target different sites in the same mRNA, we document >3-fold increase in knock-down efficiency when compared with the original HBII-180C based snoMEN. The multiplex 47snoMEM vector allowed the construction of human protein replacement cell lines with improved efficiency, including the establishment of novel GFP-HIF-1α replacement cells. Quantitative mass spectrometry analysis confirmed the enhanced efficiency and specificity of protein replacement using the 47snoMEN-PR vectors. The 47snoMEN vectors expand the potential applications for snoMEN technology in gene expression studies, target validation and gene therapy.

摘要

snoMEN(基因表达的snoRNA调节剂)载体技术是由一种人类盒C/D小核仁RNA(snoRNA)HBII-180C开发而来,它包含一个内部序列,该序列可被操控以使其与RNA靶标互补,从而实现对靶向基因的敲低。在此,我们筛选了其他人类核仁snoRNA,并评估了它们在基因特异性敲低中的应用,以提高snoMEN载体的效率。我们鉴定并表征了一种新的snoMEN载体,称为47snoMEN,它源自盒C/D snoRNA U47,证明了其可用于敲低内源性细胞蛋白和G/YFP融合蛋白。使用在单个转录本中共表达多个47snoMEN的多重47snoMEM载体,每个载体可靶向同一mRNA中的不同位点,我们证明与基于原始HBII-180C的snoMEN相比,敲低效率提高了3倍以上。多重47snoMEM载体提高了构建人类蛋白质替代细胞系的效率,包括建立新型GFP-HIF-1α替代细胞。定量质谱分析证实了使用47snoMEN-PR载体进行蛋白质替代的效率和特异性得到了提高。47snoMEN载体扩展了snoMEN技术在基因表达研究、靶点验证和基因治疗中的潜在应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7613/4851398/284ee29aa248/pone.0154759.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验